REXULTI
REXULTI
Discontinued
DIN Number
02485931
Drug Class
Human
Market Date
N/A
Company
HC
OTSUKA PHARMACEUTICAL CO., LTD.
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02485931
AIG Number0261230002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
N05AX16 BREXPIPRAZOLE
Product Specifications
Dosage FormKit
,
Tablet
Route of AdministrationOral
AHFS Classification28:16.08.04
Health Canada Classification
ACTIVE INGREDIENTS (2)
BREXPIPRAZOLEActive
Strength: 1 MG
Monograph: BREXPIPRAZOLE
BREXPIPRAZOLEActive
Strength: 2 MG
Monograph: BREXPIPRAZOLE